Crowns

Writing the playbook for cannabis marketing.

[Diamond Therapeutics @DiamondThera]

News: Diamond has received approval from Health Canada to proceed with a human clinical trial evaluating low doses of psilocybin.
https://t.co/8MMJndtYpv

[Rebecca Brown @RebeccaCrowns]

I'm representing Diamond Therapeutics at #MaRSImpactHealth, and our CEO, the amazing Judy Blumstock, is speaking. Hope to see you there. https://t.co/ltvCcU8Tfb

[Diamond Therapeutics @DiamondThera]

Diamond is proud to represent the psychedelic sector at #MaRSImpactHealth. Join us for two days of online talks, demos, debates and bold ideas from the frontlines of Canada’s healthcare revolution. Learn more from @MaRSDD

[Diamond Therapeutics @DiamondThera]

Dr. Edward Sellers, head of Diamond’s clinical advisory board, will speak about the benefits of low-dose psilocybin at the NIH Psilocybin Research Speaker Series on June 4. https://t.co/LaR9qghgzt

[Microdose Psychedelic Insights @MicrodoseHQ]

Book your spot today for the upcoming #PsyCap. The first panel of the day will include-
-Rebecca Brown, CEO & Founder of @CrownsAgency
-Terry Booth, Board of Director of @PsychedWellness
-Jeff Stevens, CEO of Psyched Wellness

Grab your FREE ticket now!
https://t.co/l8psVflYjf

[Diamond Therapeutics @DiamondThera]

A hearty congratulations to the @MAPS team and to the many patients suffering from PTSD who may be helped as a result of this study. https://t.co/SkSJIQrNCv

[Rebecca Brown @RebeccaCrowns]

Hi @erinotoole. If you're not Canada's Trump why hire the creator of Canada's Proud Boys to your campaign team? Can you explain? Seems like malarkey to me.
https://t.co/1RkXB89yQH

[Diamond Therapeutics @DiamondThera]

Thank-you, @OntarioBrain. This new investment will further Diamond's pursuit of accessible, low-dose therapies. https://t.co/NJfD6AoBdG

[Crowns @CrownsAgency]

@OneLeafCo Great news!

[The Clios @The_Clios]

Left Coast Ventures’ Ann Peltz during The Future of Cannabis Marketing #ClioCannabis panel at @EmergeCannabis.

[The Clios @The_Clios]

.@CrownsAgency's @RebeccaCrowns during The Future of Cannabis Marketing #ClioCannabis panel at @EmergeCannabis.

[The Clios @The_Clios]

.@CrownsAgency's @RebeccaCrowns during The Future of Cannabis Marketing #ClioCannabis panel at @EmergeCannabis.

[The Clios @The_Clios]

Thank you to our The Future of Cannabis Marketing #ClioCannabis panelists at @EmergeCannabis, @nudd, Ann Peltz, @ramamayo and @RebeccaCrowns.

[Rebecca Brown @RebeccaCrowns]

I stand behind this. COVID is very unfun, making fun highly valuable. Some cannabis brands have figured this out and are being more fun. This is good because pre-COVID cannabis marketing was largely unfun. Do you dig?

[The Clios @The_Clios]

Join us today at 1:30PM ET/10:30AM PT for The Future of Cannabis Marketing panel with @nudd, Ann Peltz, Rama Mayo and @RebeccaCrowns at @EmergeCannabis.

Get your tickets: https://t.co/qiEuJyaxQp

[Diamond Therapeutics @DiamondThera]

Comments from our investors JLS Fund and @NoeticFund speak to the possibility that #psychedelicmedicine can disrupt the $70 billion mental health market by developing new and better therapeutics for patients with psychiatric illnesses. https://t.co/2DKCZF28IB

[Emerge Virtual Cannabis Conference @EmergeCannabis]

Meet Rebecca Brown, @CrownsAgency Founder and powerhouse brand-builder and marketing polyglot whose career spans brand, demand and content.

Meet Rebecca and others at #WinterEmerge2020 via https://t.co/YN8e0S2olj | The world's most IMMERSIVE, INTERACTIVE, 3D #CANNABIS CONFERENCE

[Rebecca Brown @RebeccaCrowns]

Have you signed up for @emergecannabis yet? Come check out the panel, "#ClioCannabis Awards Presents The Future of Cannabis Marketing," featuring Ann Polhemus Peltz, Rama Mayo, @nudd and me. #WinterEmerge2020

[Diamond Therapeutics @DiamondThera]

Diamond puts @kejacanning's 20+ years of pharmaceutical R&D experience to good use as we advance towards our Phase 1 clinical trial of low-dose psilocybin. Learn more about our team: https://t.co/CJTl6WkDDI

[Rebecca Brown @RebeccaCrowns]

Thank you, ADCANN. It's an honour to receive this nomination for a third year and alongside these esteemed colleagues. https://t.co/dbz42A361E